Randy Milby - 25 May 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Issuer symbol
THAR
Transactions as of
25 May 2022
Net transactions value
+$786
Form type
4
Filing time
25 May 2022, 17:28:40 UTC
Previous filing
23 May 2022
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Purchase $154 +200 +0.01% $0.7700 2,936,739 25 May 2022 Direct
transaction HILS Common Stock Purchase $632 +800 +0.03% $0.7900 2,937,539 25 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.